You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CDK inhibition

Showing 26 - 50 of 2,996
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial (GSK3326595)

Completed
  • Breast Cancer
  • London, Ontario, Canada
    St. Joseph's Health Care London
Oct 24, 2022

Real-World Evidence In Patients Treated With Palbociclib

Recruiting
  • Metastatic Breast Cancer
  • Timisoara, Timiș, Romania
  • +5 more
Dec 7, 2022

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Hormone Receptor Positive Tumor Trial in Durham (Abemaciclib,

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Jun 7, 2022

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Dalpiciclib+cetuximab)

Recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    the Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
Feb 9, 2023

Solid Tumor, Adult Trial in Duarte, Nashville, San Antonio (FCN-437)

Completed
  • Solid Tumor, Adult
  • Duarte, California
  • +2 more
Mar 14, 2022

Breast Tumor Trial (Trilaciclib plus chemo, Chemotherapy)

Not yet recruiting
  • Breast Neoplasm
  • (no location specified)
May 8, 2023

Nephropathy, Diabetic Nephropathies, Diabetes, Type 1 Trial in Herlev (Sotagliflozin, Placebo)

Not yet recruiting
  • Nephropathy
  • +6 more
  • Herlev, Denmark
    Steno Diabetes Center Copenhagen
Nov 19, 2023

Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)

Recruiting
  • Triple Negative Breast Cancer
  • +5 more
  • Manchester, Greater Manchester, United Kingdom
  • +6 more
Jan 5, 2023

HER2+ Breast Cancer Trial in Xi'an (Trastuzumab, Pertuzumab, Nab paclitaxel)

Recruiting
  • HER2+ Breast Cancer
  • Xi'an, Shaanxi, China
  • +1 more
Jun 20, 2022

Prostate Cancer Trial in Birmingham (Abemaciclib 150 MG by mouth twice daily, Androgen deprivation therapy (ADT), Radiation

Recruiting
  • Prostate Cancer
  • Abemaciclib 150 MG by mouth twice daily
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham (UAB)
Mar 18, 2022

Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life Trial in Worldwide (CDK 4/6 inhibitors, Endocrine therapy)

Not yet recruiting
  • Metastatic Breast Cancer
  • +4 more
  • CDK 4/6 inhibitors
  • Endocrine therapy
  • Helsinki, Finland
  • +11 more
Sep 19, 2023

Solid Tumor, Adult, Lymphoma Trial in Korea, Republic of, Spain, United States (Fadraciclib)

Recruiting
  • Solid Tumor, Adult
  • Lymphoma
  • Duarte, California
  • +3 more
Apr 1, 2022

Leukemia, Myelodysplastic Syndrome(MDS) Trial in Duarte, Houston (fadraciclib)

Recruiting
  • Leukemia
  • Myelodysplastic Syndrome(MDS)
  • Duarte, California
  • +1 more
Apr 1, 2022

Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

Not yet recruiting
  • Advanced Clear Cell Renal Carcinoma (Ccrcc)
  • Papillary Renal Cell Carcinoma (Prcc)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

MDS (MDS) Trial in United States (Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine)

Completed
  • Myelodysplastic Syndromes (MDS)
  • Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine
  • Chicago, Illinois
  • +11 more
Apr 4, 2022

Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in

Recruiting
  • Breast Cancer
  • CT scans
  • DEXA scan
  • Bronx, New York
    Montefiore Medical Center
Jan 6, 2023

Breast Cancer Trial in Los Angeles, Bronx (Gedatolisib, Faslodex, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Los Angeles, California
  • +1 more
Jan 25, 2022

NSCLC Metastatic, NSCLC Stage III Trial in Worldwide (Avelumab, Axitinib, Palbociclib)

Active, not recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Non-small Cell Lung Cancer Stage III
  • La Jolla, California
  • +5 more
Aug 12, 2022

Head Neck Cancer, Advanced Cancer, Metastatic Cancer Trial in Bordeaux, Lyon, Nice (Abemaciclib)

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Bordeaux, France
  • +2 more
Jul 22, 2022

Solid Tumors Trial (ARTS-021, CDK 4/6 inhibitor, Fulvestrant 50 MG/ML Prefilled Syringe)

Not yet recruiting
  • Solid Tumors
  • (no location specified)
May 17, 2023

Advanced Solid Tumor Trial in United Kingdom, United States (CDK-002)

Active, not recruiting
  • Advanced Solid Tumor
  • CDK-002
  • Scottsdale, Arizona
  • +7 more
Sep 27, 2022

NHL, Leukemia Trial in Australia (ETH-155008)

Recruiting
  • NHL
  • Leukemia
  • Adelaide, South Australia, Australia
  • +4 more
Jun 8, 2022

Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer Trial in Houston (IDE-161)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • +4 more
  • Houston, Texas
    MD Anderson
Mar 27, 2023

Breast Cancer Trial in Singapore (Lenvatinib + Letrozole, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • Singapore, Singapore
    Nationa University Hospital
Jan 4, 2022

Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer, HER2-Negative Breast Cancer, Metastatic Epithelial Ovarian Cancer

Terminated
  • Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Mar 16, 2022